These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26902485)

  • 1. Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Rai M; Ahlberg AW; Marwell J; Chaudhary W; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2017 Apr; 24(2):724-734. PubMed ID: 26902485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S; Ahlberg AW; Rai M; Perucki WH; Felpel KD; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
    El-Hajj S; AlJaroudi WA; Farag A; Bleich S; Manaoragada P; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Feb; 23(1):101-12. PubMed ID: 26017713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
    Farzaneh-Far A; Shaw LK; Dunning A; Oldan JD; O'Connor CM; Borges-Neto S
    J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece.
    Koutsikos J; Angelidis G; Zafeirakis A; Mamarelis I; Vogiatzis M; Ilia E; Lazaridis K; Demakopoulos N
    Hell J Nucl Med; 2017; 20(3):232-236. PubMed ID: 29177261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of regadenoson myocardial perfusion imaging.
    Hage FG; Ghimire G; Lester D; Mckay J; Bleich S; El-Hajj S; Iskandrian AE
    J Nucl Cardiol; 2015 Dec; 22(6):1214-21. PubMed ID: 25677160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis?
    Azemi T; Rai M; Parwani P; Baghdasarian S; Kazi F; Ahlberg AW; Cyr G; Katten D; O'Sullivan D; Fram D; Heller GV
    J Nucl Cardiol; 2012 Feb; 19(1):84-91. PubMed ID: 21947978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
    Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC
    J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W; Campagnoli T; Fughhi I; Wassouf M; Ali A; Doukky R
    J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
    Parker MW; Morales DC; Slim HB; Ahlberg AW; Katten DM; Cyr G; Mathur S; Ardestani A; Barmpouletos D; Iyah GS; Borer SM; Heller GV
    J Nucl Cardiol; 2013 Apr; 20(2):185-96. PubMed ID: 23188626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of myocardial perfusion imaging in octogenarians able to undergo treadmill exercise stress testing.
    Katsikis A; Theodorakos A; Papaioannou S; Tsapaki V; Kolovou G; Drosatos A; Koutelou M
    J Nucl Cardiol; 2014 Dec; 21(6):1213-22. PubMed ID: 25189145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.
    Lin LF; Cheng CY; Hou CH; Ku CH; Tseng NC; Shen DH
    J Nucl Cardiol; 2014 Jun; 21(3):563-9. PubMed ID: 24627347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis.
    Hussain N; Chaudhry W; Ahlberg AW; Amara RS; Elfar A; Parker MW; Savino JA; Titano R; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2017 Aug; 24(4):1200-1213. PubMed ID: 26979307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    Doran JA; Sajjad W; Schneider MD; Gupta R; Mackin ML; Schwartz RG
    J Nucl Cardiol; 2017 Jun; 24(3):1062-1070. PubMed ID: 27025843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for large artery or chronic coronary artery disease-related ischemic stroke in octogenarians undergoing exercise stress myocardial perfusion imaging: A cohort study.
    Katsikis A; Theodorakos A; Drosatos A; Konstantinou K; Papaioannou S; Koutelou M
    J Nucl Cardiol; 2017 Apr; 24(2):591-595. PubMed ID: 26676028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Tejani FH; Thompson RC; Iskandrian AE; McNutt BE; Franks B
    J Nucl Cardiol; 2011 Feb; 18(1):73-81. PubMed ID: 21082298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine triphosphate stress myocardial perfusion imaging for risk stratification of patients aged 70 years and older with suspected coronary artery disease.
    Yao Z; Zhu H; Li W; Chen C; Wang H; Shi L; Zhang W
    J Nucl Cardiol; 2017 Apr; 24(2):429-433. PubMed ID: 26797919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.